Featured Articles

Mallinckrodt to acquire Sucampo Pharmaceuticals for approximately $1.2 Billion

Read more

Teva Announces Exclusive Launch of a Generic Version of Reyataz in the U.S.

Read more

Recipharm acquires remaining shares in Nitin Lifesciences Ltd

Read more

Nanobiotix’s first immuno-oncology trial approved by U.S. FDA

Read more

Avista Pharma Solutions expands Drug Product cGMP Manufacturing at Colorado Site

Read more

Regeneron and ISA Pharmaceuticals announce Strategic Immuno-Oncology Collaboration

Read more

Abzena secures ADC manufacturing services contract

Read more

Roche lymphoma drug drives high remission rate, longer survival

Read more

GSK submits US regulatory application for single-dose tafenoquine for P. vivax malaria

Read more

Brammer Bio Launches Gene Therapy Product Manufacturing Operations in Massachusetts

Read more